MAP3K8 kinase regulates myeloma growth by cell‐autonomous and non‐autonomous mechanisms involving myeloma‐associated monocytes/macrophages

No abstract is available for this paper.

• Publication year

  2013

• Venue

  British Journal of Haematology

• Publication date

  2013-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/bjh.12175PMID 23252623PMCID PMC3594344
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cot/tpl2-MKK1/2-Erk1/2 controls mTORC1-mediated mRNA translation in Toll-like receptor–activated macrophages

  2012cited by this paper
• Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells

  2012cited by this paper
• Macrophage plasticity and polarization: in vivo veritas.

  2012cited by this paper
• Tpl2 ablation promotes intestinal inflammation and tumorigenesis in Apcmin mice by inhibiting IL-10 secretion and regulatory T-cell generation

  2012cited by this paper
• Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells

  2012cited by this paper
• Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase

  2011cited by this paper
• Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase

  2011cited by this paper
• Faculty Opinions recommendation of COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.

  2011influential reference
• Cot/tpl2 activity is required for TLR‐induced activation of the Akt p70 S6k pathway in macrophages: Implications for NO synthase 2 expression

  2011cited by this paper
• COT/MAP3K8 drives resistance to RAF inhibition through MAP kinase pathway reactivation

  2010cited by this paper
• Macrophage diversity enhances tumor progression and metastasis.

  2010cited by this paper
• The role of monocytes-macrophages in vasculogenesis in multiple myeloma

  2009cited by this paper
• Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis.

  2009cited by this paper
• The TSC-mTOR signaling pathway regulates the innate inflammatory response.

  2008cited by this paper
• Tpl2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40

  2003cited by this paper
• The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications.

  2001influential reference
• TNF-a Induction by LPS Is Regulated Posttranscriptionally via a Tpl2/ERK-Dependent Pathway

  2000cited by this paper
• TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway.

  2000cited by this paper

• Tumor progression locus 2, a new potential prognostic factor and therapeutic target in activated B-cell-like diffuse large B-cell lymphoma

  2025cites this paper
• Targeting the CD47-SIRPalpha checkpoint in multiple myeloma

  2025cites this paper
• Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial

  2024cites this paper
• Epigenetic Regulation of MAP3K8 in EBV-Associated Gastric Carcinoma

  2023cites this paper
• First-in-human clinical trial of personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma

  2023cites this paper
• Melatonin Protects the Apoptosis of Sheep Granulosa Cells by Suppressing Oxidative Stress via MAP3K8 and FOS Pathway

  2023cites this paper
• Establishment and characterization of a new activated B-cell-like DLBCL cell line, TMD12.

  2022cites this paper
• β2-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progression.

  2021cites this paper
• BMI1 regulates multiple myeloma-associated macrophage’s pro-myeloma functions

  2021cites this paper
• Cytotoxicity of apigenin toward multiple myeloma cell lines and suppression of iNOS and COX-2 expression in STAT1-transfected HEK293 cells.

  2020cites this paper
• Extracellular matrix and the myeloid‐in‐myeloma compartment: balancing tolerogenic and immunogenic inflammation in the myeloma niche

  2017cites this paper
• Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma

  2015cites this paper
• TPL2 kinase regulates the inflammatory milieu of the myeloma niche.

  2014cites this paper
• Macrophages in multiple myeloma: emerging concepts and therapeutic implications

  2013cites this paper
• Decoding the pathophysiology and the genetics of multiple myeloma to identify new therapeutic targets.

  2013cites this paper